Signed an MOU for business cooperation with Hiple Co., Ltd.

Daeryun Law Firm (Limited) announced that it has signed a legal advisory MOU for mutual development with Hiple Co., Ltd.

Daeryun Co., Ltd. announced on March 2024. It was announced on the 11th that Daeryun's CEO Kuk-il Kim, Chief General Counsel Won Il Won, and CEO Jae-min Cho of Hiple Co., Ltd. attended the agreement ceremony held at KDB Life Tower, the headquarters of KDB in Seoul. We are supplying raw materials to domestic and foreign pharmaceutical companies through pharmaceutical research and development, manufacturing, and distribution.

Through this agreement, Daeryun provides ▲ legal consultation for executives and employees ▲ legal advice on international transactions ▲ review of certification and patents ▲ in-house personnel and labor advice. ▲Supports representation in civil and criminal litigation.

In addition, Daeryun plans to provide three-dimensional and comprehensive legal advice by utilizing specialized groups in each field, including medical care, corporate law, intellectual property rights, fair trade, and customs and international trade.

In addition, we plan to manage major legal issues such as the Fair Trade Act, Labor Standards Act, and Occupational Safety and Health Act, and review whether there are any violations of local laws related to overseas investment. “Issues such as fair trade and serious accidents are constantly emerging, so we will provide focused legal advice on these issues,” he said. “We will help Hiple, which is engaged in international contracts and overseas investments, to grow into a global company.” Domestic pharmaceutical regulations are so severe that problems such as deviations in various processes are more common in the pharmaceutical industry than in other occupations,” he said, adding, “With Daeryun’s legal support, we expect work efficiency to increase in areas such as fair trade, overlapping trade regulations, and restructuring strategy planning after the acquisition of Dongindang Pharmaceutical.” style="background-color:white;color:rgb(48,48,56);">Daeryun CEO Kim Kuk-il said, "Daeryun's medical specialty group can respond quickly to drug-related incidents and accidents. In particular, we also operate various professional groups, including civil and criminal, that can flexibly resolve linked cases," and added, "We will continue to discuss pending issues that arise in the field with Hiple and expand the corporate advisory field to achieve win-win development." revealed.